The News
Propel Software, a product value management platform vendor built on Salesforce, has published its annual business and technology predictions for 2027. CEO Ross Meyercord identifies five trends shaping manufacturing and MedTech sectors in the coming year: AI shifting from a perceived SaaS disruptor to a SaaS amplifier, AI governance moving from human-in-the-loop toward human-in-the-audit-trail, healthcare delivery migrating further into the home, manufacturers rebuilding tech stacks to serve AI rather than bolt AI onto existing stacks, and AI investment moving from boardroom demonstrations to measurable operational throughput. The predictions are positioned around Propel’s core product value management platform, which connects product lifecycle, quality, and commercial workflows for companies in high tech, MedTech, and consumer goods.
Analyst Take
The SaaS-Plus-AI Narrative Is Self-Serving, But It’s Also Correct
Propel’s lead prediction, that AI will prove to be a SaaS kingmaker rather than a SaaS killer, is conveniently aligned with Propel’s own business model. That doesn’t make it wrong. The more credible version of this argument is structural: AI models are only as useful as the context they can access, and context lives in systems of record. A manufacturer’s bill of materials, quality records, and service history aren’t sitting in a generic large language model. They’re in PLM, ALM, and ERP platforms. Propel’s point that “AI and Model Context Protocol connections will help bridge some systems, but they won’t replace missing data or capabilities” is a more honest framing than most vendors offer. The companies that will struggle in 2027 are not those that lack AI features. They’re the ones that lack clean, connected data for AI to act on.
For ITDMs in manufacturing and MedTech, this prediction carries a concrete budget implication: before investing in AI tooling, the investment case for data consolidation and system-of-record modernization gets stronger, not weaker. That’s a harder sell internally than a shiny AI pilot, but it’s the right sequencing.
Governance Is the Sleeper Issue in the Audit Trail Prediction
The second prediction, that human oversight will shift from active review to periodic audit, is the one most likely to catch organizations flat-footed. Propel frames this as a natural progression as AI embeds subject matter expertise from experienced employees. The governance challenge this creates is real and underappreciated: when AI makes the call on a routine engineering change or a quality disposition, who is accountable when it’s wrong? The audit log answers the forensic question after the fact. It doesn’t prevent the error.
This is especially salient for regulated industries. MedTech companies operating under FDA design control requirements and manufacturers navigating ISO quality systems cannot simply trust AI recommendations and review them quarterly. The shift from human-in-the-loop to human-in-the-audit-trail is a governance posture change that requires deliberate policy design, not just a software feature. Organizations that treat audit logging as a compliance checkbox rather than a risk management instrument will find themselves exposed.
The Operational Shift That Matters Most
The fifth prediction, AI moving from boardroom demonstrations to everyday throughput metrics, is where Propel’s analysis is sharpest. The framing that executive teams will judge AI by its impact on throughput, quality, risk, and margin rather than pilot attention aligns well with how mature technology adoption cycles actually resolve. Early AI deployments in manufacturing have frequently targeted visible, high-complexity problems precisely because they attract budget and executive sponsorship. The next phase favors the mundane: automating engineering handoffs, verification tasks, and delivery workflows.
ECI Research’s Google GovTech Survey found that 49.6% of respondents estimated that 26% to 50% of their organization’s code would be assisted or generated by AI within the next 12 months, a level of AI integration that implies AI is already moving well beyond pilot status in many organizations. Separately, the same survey found that 35.8% of respondents identified “Team Integration / Apps” (collaborative ecosystem tools, automated testing, and secure API code scanning integrated into CI/CD) as the area where AI tools are seeing the highest active adoption. That’s consistent with Propel’s prediction: the action is shifting from exploratory to operational, from the demo room to the CI/CD pipeline and the engineering workflow. For Propel specifically, this trend validates the design of a connected platform that spans product, quality, and commercial data rather than point solutions.
Developers should note that this operational shift creates demand for deterministic, auditable AI behavior in production workflows, not just generative assistance in the IDE. The architecture question is no longer “can AI help my developers write code faster” but “can AI reliably execute a cross-system workflow with the right guardrails and a recoverable audit trail.”
Looking Ahead
Propel’s 2027 predictions collectively point toward a market dynamic that favors depth over breadth in enterprise software. The vendors most exposed are those that added AI as a surface feature on top of fragmented data architectures. The vendors best positioned are those with unified data models that give AI agents reliable, contextual access across the product or application lifecycle. Propel is making a clear bet that its Salesforce-native, connected-platform approach places it in the latter category. The bet is credible, but execution will determine whether the platform can handle the data volume and workflow complexity that AI-at-scale in MedTech and manufacturing actually demands.
Watch for two signals over the next four to six quarters. First, whether manufacturers actually consolidate system-of-record investments before or alongside AI tool adoption, or whether they continue bolting AI onto fragmented stacks and accepting diminished returns. Second, whether the regulatory environment for AI in regulated manufacturing catches up to the governance posture Propel describes. FDA’s evolving position on AI/ML in Software as a Medical Device and the broader push toward continuous authorization models in enterprise software suggest that the audit trail will become a compliance requirement, not just a best practice. Organizations that build the governance infrastructure now will have a meaningful head start.
Stay Ahead of Application Development Trends
Get weekly analyst insights, research notes, event coverage, and AppDevANGLE updates delivered directly to your inbox.
Subscribe for Weekly Insights
Join technology leaders, practitioners, and GTM teams following the trends shaping modern software delivery.
Looking for deeper research access?
Explore ECI Research reports, survey insights, and market analysis through the ECI Research Portal.
